<DOC>
	<DOCNO>NCT00259298</DOCNO>
	<brief_summary>The purpose study evaluate effect teriparatide skeleton image postmenopausal woman osteoporosis . Teriparatide bone formation agent stimulate production new bone skeleton . This process bone formation study use technique commonly refer bone scan nuclear scintigraphy . This trial test whether bone scan identify area skeleton form new bone teriparatide therapy . It also study area look like therapy stop .</brief_summary>
	<brief_title>Evaluation Effects Teriparatide Skeleton Images Postmenopausal Women With Osteoporosis</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<criteria>Ambulatory osteoporosis Hip spine bone mineral density ( BMD ) measurement 2.5 standard deviation average bone mass young healthy woman 2.0 standard deviation woman history vertebral nonvertebral fragility fracture . Diseases bone osteoporosis Treatment estrogens 3 month prior enrollment 2 month past year Treatment oral bisphosphonates 3 month prior enrollment 2 month past year ; treatment intravenous bisphosphonates 12 month prior enrollment Increased risk development osteosarcoma</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>